Early signs on how a reorganization is playing out at Fullerton-based Beckman Coulter Inc. are due later this week.
The county’s largest medical device company is set to release fourth-quarter results on Friday, the latest in a string of closely watched reports from big local companies.
The burning question: Will Chief Executive Scott Garrett’s move last year to combine two businesses and change the way sales are reported pay off?
Wall Street is waiting. Beckman Coulter’s shares have posted just subtle gains in recent weeks after slipping in the fall. The company counted a recent market value of $3.6 billion.
Beckman Coulter makes equipment and supplies for labs running tests for doctors and for medical and drug researchers.
Analysts expect the company to earn $45.3 million for the fourth quarter, off about 25% from a year earlier. Sales are seen coming in at $667.4 million, down 3% from a year ago.
For more on this story, see the Feb. 13 edition of the Business Journal.
